Fredun Pharmaceuticals Ltd Share Price & Stock Analysis

Fredun Pharmaceuticals Ltd (BSE: 539730) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹2,527 Cr, it ranks #1,134 by market cap among the 6,197 Indian listed companies on FinBizNet, and #35 of 86 in Medicinal Chemicals and Botanical Products. At ₹1,503.00 (as of 16 Nov 2026), the share price is 9.7% below its 52-week high of ₹1,665.00 and 25.8% above its 52-week low of ₹1,195.20. The share price is up 238.8% over one year and up 67.4% over three months.

Key Metrics

Current Price₹1,503.00
Market Cap₹2,527 Cr
BSE Code539730
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio74.7
Return on Equity15.55%
Return on Assets9.14%
52-Week Range₹1,195.20 – ₹1,665.00
1-Year Price Change+238.8%
3-Month Price Change+67.4%
Beta (1Y)0.47
Dividend Yield0.02%
HeadquartersMumbai, Maharashtra
Websitewww.fredungroup.com

Shareholding and Delivery

Delivery averaged 46.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, anti-bacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, antibacterial, analgesics, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannula, disposable syringes, infusion sets, surgical gloves and

Products and Services

1. Pharmaceutical Formulations-This segment manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products. It also provides animal healthcare products, as well as allopathic formulations and on field diagnostic kits.

Business Segments

1. Pharmaceutical and Healthcare-100%

Fredun Pharmaceuticals Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Fredun Pharmaceuticals Ltd₹2,527 Cr74.715.55%—+238.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd is trading at ₹1,503.00, with a market capitalisation of ₹2,527 Cr.

Which sector does Fredun Pharmaceuticals Ltd belong to?

Fredun Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd has a P/E of 74.7 and a return on equity of 15.55%.

What is the stock symbol of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd is listed on the BSE under the scrip code 539730.

How has Fredun Pharmaceuticals Ltd's share price moved over the past year?

Fredun Pharmaceuticals Ltd's share price is up 238.8% over one year and up 67.4% over three months. Its 52-week range is ₹1,195.20 to ₹1,665.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.